The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The TyG index may predict the development of cardiovascular events
Abstract
Background: Cardiovascular disease (CVD) is the worldwide leading cause of morbidity and mortality. An early risk detection of apparently healthy people before CVD onset has clinical relevance in the prevention of cardiovascular events. We evaluated the association between the product of fasting plasma glucose and triglycerides (TyG index) and CVD. Material and methods: A total of 5014 patients of the Vascular Metabolic CUN cohort (VMCUN cohort) were followed up during a median period of 10 years. We used a Cox proportional‐hazard ratio with repeated measures to estimate the risk of incidence of CVD across quintiles of the TyG index, calculated as ln[fasting triglycerides (mg/dL) × fasting plasma glucose (mg(dL)/2], and plotted a receiver‐operating characteristics (ROC) curve to compare a prediction model fitted on the variables used in the Framingham risk score, a new model containing the Framingham variables with the TyG index, and the risk of coronary heart disease. Results: A higher level of TyG index was significantly associated with an increased risk of developing CVD independent of confounding factors with a value of 2·32 (95% CI: 1·65–3·26) for those in the highest quintile and 1·52 (95% CI: 1·07–2·16) for those in the fourth quintile. The areas under the curve (AUC) of the ROC plots were 0·708 (0·68–0·73) for the Framingham model and 0·719 (0·70–0·74) for the Framingham + TyG index model (P = 0·014). Conclusions: The TyG index, a simple measure reflecting insulin resistance, might be useful to early identify individuals at a high risk of developing a cardiovascular event.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
Self-citationRetractedDetection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0034 · Cited by 2,445
Guerrero-Romero, F., Simental-Mendía, L. E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M. G., Hernández-González, S. O., Jacques-Camarena, O., & Rodríguez-Morán, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0288 · Cited by 2,247
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Cited by
Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
Tao, L.-C., Xu, J.-N., Wang, T.-T., Hua, F., & Li, J.-J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01511-x · Cited by 1,042
Dang, K., Wang, X., Hu, J., Zhang, Y., Cheng, L., Qi, X., Liu, L., Ming, Z., Tao, X., & Li, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02115-9 · Cited by 599
Ding, X., Wang, X., Wu, J., Zhang, M., & Cui, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01268-9 · Cited by 454
Wang, L., Cong, H.-L., Zhang, J.-X., Hu, Y.-C., Wei, A., Zhang, Y.-Y., Yang, H., Ren, L.-B., Qi, W., Li, W.-Y., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01054-z · Cited by 435
Liu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., Ma, J., Zhao, Y., Zhu, W., & Wang, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01546-0 · Cited by 409
Navarro-González, D., Sánchez-Íñigo, L., Pastrana-Delgado, J., Fernández-Montero, A., & Martinez, J. A. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.01.022 · Cited by 403
Self-citationElevated TyG Index Predicts Progression of Coronary Artery Calcification
Park, K., Ahn, C. W., Lee, S. B., Kang, S., Nam, J. S., Lee, B. K., Kim, J. H., & Park, J. S. (2019) · Diabetes Care · doi:10.2337/dc18-1920 · Cited by 392
Lopez-Jaramillo, P., Gomez-Arbelaez, D., Martinez-Bello, D., Abat, M. E. M., Alhabib, K. F., Avezum, Á., Barbarash, O., Chifamba, J., Diaz, M. L., Gulec, S., et al. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(22)00247-1 · Cited by 386
Che, B., Zhong, C., Zhang, R., Pu, L., Zhao, T., Zhang, Y., & Han, L. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01762-2 · Cited by 382
Hong, S., Han, K., & Park, C.-Y. (2020) · BMC Medicine · doi:10.1186/s12916-020-01824-2 · Cited by 376
Zhao, S., Yu, S., Chi, C., Fan, X., Tang, J., Ji, H., Teliewubai, J., Zhang, Y., & Xu, Y. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0898-x · Cited by 324
Association between triglyceride glucose index and arterial stiffness in Korean adults
Lee, S. B., Ahn, C. W., Lee, B. K., Kang, S., Nam, J. S., You, J. H., Kim, M. J., Kim, M. K., & Park, J. S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0692-1 · Cited by 305
Luo, E., Wang, D., Yan, G., Qiao, Y., Liu, B., Hou, J., & Tang, C. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0957-3 · Cited by 304
da Silva, A., Caldas, A. P. S., Hermsdorff, H. H. M., Bersch-Ferreira, Â. C., Torreglosa, C. R., Weber, B., & Bressan, J. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0893-2 · Cited by 299
Jin, J.-L., Cao, Y.-X., Wu, L.-G., You, X.-D., Guo, Y.-L., Wu, N.-Q., Zhu, C.-G., Gao, Y., Dong, Q.-T., Zhang, H.-W., et al. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.10.79 · Cited by 288
Zhang, S., Du, T., Zhang, J., Lu, H., Lin, X., Xie, J., Yang, Y., & Yu, X. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0409-6 · Cited by 284
Barzegar, N., Tohidi, M., Hasheminia, M., Azizi, F., & Hadaegh, F. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01121-5 · Cited by 261
Yassin, A., Haider, A., Haider, K. S., Caliber, M., Doros, G., Saad, F., & Garvey, W. T. (2019) · Diabetes Care · doi:10.2337/dc18-2388 · Cited by 164
Zhang, Y., Ding, X., Hua, B., Liu, Q., Gao, H., Chen, H., Zhao, X.-Q., Li, W., & Li, H. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.61119 · Cited by 78
Leite, M. M., Dutra, M. T., da Costa, M. V. G., Funghetto, S. S., Silva, A. D. O., de Lima, L. R., da Silva, I. C. R., Mota, M. R., & Stival, M. M. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111389 · Cited by 15
Sánchez-Iñigo, L., Navarro-González, D., Martinez-Urbistondo, D., Pastrana, J. C., Fernandez-Montero, A., & Martinez, J. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1087554 · Cited by 5
Self-citationHarahap, I. A., Salem, O., Fahmi, R. L., Ahmed, N., Leciejewska, N., & Suliburska, J. (2025) · Nutrients · doi:10.3390/nu17182917 · Cited by 2
Metadata
- Authors
- Sánchez‐Íñigo, L., Navarro‐González, D., Fernández‐Montero, A., Pastrana‐Delgado, J., & Martínez, J. A.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2016-01-23
- Volume
- 46
- Issue
- 2
- Pages
- 189-197
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2217853646
- Cited by
- 663
- References
- 42
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.